Document is current
Any future updates will be listed below
-
Authors
-
Funding
Funding for this research was provided by:
Vetenskapsrådet (2016-02349)
Vetenskapsrådet (2020-01998)
Forskningsrådet om Hälsa, Arbetsliv och Välfärd (2015-00195)
Forskningsrådet om Hälsa, Arbetsliv och Välfärd (2019-00697)
Swedish Brain Foundation (FO2020-0077)
Swedish Brain Foundation (FO2024-0344)
Margareta af Ugglas Foundation
Swedish Foundation for MS Research
Neuro Sweden
Karolinska Institute
- License Information
-
More Information
Article History
Received: 5 January 2026
Revised: 8 February 2026
Accepted: 10 February 2026
First Online: 21 February 2026
Declarations
:
: J. Guo reports no disclosures relevant to this manuscript; T. Olsson has received lecture/advisory board honoraria, and unrestricted MS research grants from Biogen, Novartis, Sanofi, and Merck; L. Alfredsson has received personal fees from Teva and Biogen; A.K. Hedström reports no disclosures relevant to this manuscript.
